Bharathi Anekella

Dr. Bharathi Anekella joined Seracare in 2000, which was subsequently acquired by LGC.

Bharathi served as Senior Vice President of Product Development and Technical Operations since 2014 and in 2021, assumed leadership of LGC Clinical Diagnostics as its Executive Vice President and General Manager.

Prior to joining Seracare, Bharathi was a lead scientist at DNA Technologies where she developed molecular assays and managed contract manufacturing. She has more than 25 years of experience in technology and product development in infectious disease, oncology, genetic disease and recombinant virus. Bharathi has a PhD in microbiology from Osmania University, India.